Vaccine developers are accelerating efforts to combat the rare Bundibugyo strain of Ebola as cases rise in Congo and Uganda, according to Bloomberg.
IAVI Chief Executive Officer Mark Feinberg said a candidate vaccine could enter human trials by year-end.
Ebola Vaccine Trials Could Start This Year, IAVI CEO Says
2026-07-04 05:02:00
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
